Alantra, the independent global mid-market investment banking firm, has advised the shareholders of Prescient Healthcare Group (Prescient), a global product strategy advisory firm serving the pharmaceutical and biotech industries, on investment by Bridgepoint Development Capital, replacing current investor Baird Capital as the majority shareholder.
